MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 66 filers reported holding MIRATI THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 1.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $1,977,000 | -43.8% | 62,813 | -47.6% | 0.01% | -37.5% |
| Q1 2015 | $3,516,000 | +90.1% | 119,912 | +20.0% | 0.01% | +100.0% |
| Q4 2014 | $1,850,000 | +5.8% | 99,912 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $1,749,000 | -12.5% | 99,912 | 0.0% | 0.00% | -20.0% |
| Q2 2014 | $1,998,000 | -30.1% | 99,912 | -33.4% | 0.01% | -37.5% |
| Q1 2014 | $2,859,000 | -55.6% | 149,912 | -61.3% | 0.01% | -55.6% |
| Q4 2013 | $6,441,000 | – | 387,325 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |